Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ICU | US
-0.04
-1.36%
Healthcare
Biotechnology
30/06/2024
08/06/2026
2.90
2.93
3.06
2.81
SeaStar Medical Holding Corporation a medical device company develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. SeaStar Medical Holding Corporation is headquartered in Denver Colorado.
View LessLow Debt to Equity (< 0.25)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
49.2%1 month
60.4%3 months
120.2%6 months
109.1%-
-
-
-0.46
0.91
-8.13
-
-
-
12.16M
12.16M
-
-
-
-
-
3.59
5.29
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.14
Range1M
2.17
Range3M
3.03
Rel. volume
1.16
Price X volume
267.36K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| CytoMed Therapeutics Limited Ordinary Shares | GDTC | Biotechnology | 1.15 | 13.27M | -10.85% | n/a | 3.98% |
| Marker Therapeutics Inc | MRKR | Biotechnology | 1.46 | 13.03M | 2.82% | n/a | 0.00% |
| PLUR | PLUR | Biotechnology | 2.31 | 12.64M | -2.12% | n/a | 30845.83% |
| Kala Pharmaceuticals Inc | KALA | Biotechnology | 2.29 | 12.55M | 11.16% | n/a | 268.29% |
| XTL Biopharmaceuticals Ltd | XTLB | Biotechnology | 2.23 | 12.15M | 8.25% | n/a | 0.00% |
| GeoVax Labs Inc | GOVX | Biotechnology | 1.34 | 11.42M | -18.79% | n/a | -6.03% |
| Lipocine Inc | LPCN | Drug Manufacturers-Specialty & Generic | 2.04 | 10.91M | -0.49% | n/a | 0.00% |
| Longeveron Inc. Class A Common Stock | LGVN | Biotechnology | 0.754 | 10.83M | 3.29% | n/a | 11.72% |
| CALC | CALC | Biotechnology | 0.958 | 10.30M | -9.62% | n/a | 0.00% |
| Cocrystal Pharma Inc | COCP | Biotechnology | 1.01 | 10.28M | 4.74% | n/a | 10.24% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.4131 | 7.98M | -3.48% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.49 | 3.81M | 12.88% | n/a | 17.32% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0058 | 534.84K | n/a | -37.05% | |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4181 | 230.37K | 7.87% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -8.13 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 120.20 | 72.80 | Riskier |
| Debt to Equity | -0.46 | -1.23 | Expensive |
| Debt to Assets | 0.91 | 0.25 | Expensive |
| Market Cap | 12.16M | 3.66B | Emerging |